Long-term, open-label safety study of oral almotriptan 12.5 mg for the acute treatment of migraine in adolescents

Headache

Volumn 50, Issue 5, 2010, Pages 795-807

  Berenson, Frank ^a   Vasconcellos, Elza ^b   Pakalnis, Ann ^c   Mao, Lian ^d   Biondi, David M ^d   Armstrong, Robert B ^d  

^a Child Neurology Associates   (United States)

^b MIAMI CHILDREN'S HOSPITAL   (United States)

^c THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

^d JANSSEN RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Adolescents; Almotriptan; Migraine; Safety; Tolerability

Indexed keywords

ALMOTRIPTAN;

ABDOMINAL PAIN; ADOLESCENT; ADOLESCENT DISEASE; ANALGESIA; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG FATALITY; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ELECTROCARDIOGRAPHY MONITORING; FEMALE; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MIGRAINE; MUSCLE SPASM; NAUSEA; NAUSEA AND VOMITING; NOSE CONGESTION; PAIN ASSESSMENT; PHONOPHOBIA; PHOTOPHOBIA; PRIORITY JOURNAL; RHINOPHARYNGITIS; SCHOOL CHILD; SINUSITIS; SOMNOLENCE; SORE THROAT; STREPTOCOCCAL PHARYNGITIS; SYNCOPE; TREATMENT DURATION; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT INFECTION; VITAL SIGN; VOMITING;

ACUTE DISEASE; ADMINISTRATION, ORAL; ADOLESCENT; CHILD; FEMALE; HUMANS; MALE; MIGRAINE DISORDERS; SEROTONIN RECEPTOR AGONISTS; TIME FACTORS; TRYPTAMINES;

EID: 77951867481     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2010.01655.x     Document Type: Article

References (31)

1. Perrin VL, Farkkila M, Goasguen J, Doenicke A, Brand J, Tfelt-Hansen P. Overview of initial clinical studies with intravenous and oral GR43175 in acute migraine. Cephalalgia. 1989 9 (Suppl. 9 63 72. (Pubitemid 19131505)
2. Split W, Neuman W. Epidemiology of migraine among students from randomly selected secondary schools in Lodz. Headache. 1999 39 : 494 501. (Pubitemid 29400302)
3. Winner P, Rothner AD, Saper J, et al. A randomized, double-blind, placebo-controlled study of sumatriptan nasal spray in the treatment of acute migraine in adolescents. Pediatrics. 2000 106 : 989 997.
4. Winner P, Rothner AD, Wooten JD, Webster C, Ames M. Sumatriptan nasal spray in adolescent migraineurs: A randomized, double-blind, placebo-controlled, acute study. Headache. 2006 46 : 212 222.
5. Lewis DW, Winner P, Hershey AD, Wasiewski WW. Efficacy of zolmitriptan nasal spray in adolescent migraine. Pediatrics. 2007 120 : 390 396. (Pubitemid 47219510)
6. Visser WH, Winner P, Strohmaier K, et al. Rizatriptan 5 mg for the acute treatment of migraine in adolescents: Results from a double-blind, single-attack study and two open-label, multiple-attack studies. Headache. 2004 44 : 891 899. (Pubitemid 39362313)
7. Winner P, Lewis D, Visser WH, Jiang K, Ahrens S, Evans JK. Rizatriptan 5 mg for the acute treatment of migraine in adolescents: A randomized, double-blind, placebo-controlled study. Headache. 2002 42 : 49 55. (Pubitemid 34136611)
8. Rothner AD, Wasiewski W, Winner P, Lewis D, Stankowski J. Zolmitriptan oral tablet in migraine treatment: High placebo responses in adolescents. Headache. 2006 46 : 101 109.
9. Winner P, Linder SL, Lipton RB, Almas M, Parsons B, Pitman V. Eletriptan for the acute treatment of migraine in adolescents: Results of a double-blind, placebo-controlled trial. Headache. 2007 47 : 511 518. (Pubitemid 46625260)
10. Charles JA. Almotriptan in the acute treatment of migraine in patients 11-17 years old: An open-label pilot study of efficacy and safety. J Headache Pain. 2006 7 : 95 97.
11. Linder SL, Mathew NT, Cady RK, Finlayson G, Ishkanian G, Lewis DW. Efficacy and tolerability of almotriptan in adolescents: A randomized, double-blind, placebo-controlled trial. Headache. 2008 48 : 1326 1336.
12. Cady RK, Sheftell F, Lipton RB, et al. Effect of early intervention with sumatriptan on migraine pain: Retrospective analyses of data from three clinical trials. Clin Ther. 2000 22 : 1035 1048.
13. Cady RK, Lipton RB, Hall C, Stewart WF, O'Quinn S, Gutterman D. Treatment of mild headache in disabled migraine sufferers: Results of the Spectrum Study. Headache. 2000 40 : 792 797. (Pubitemid 32053239)
14. Lainez M. Clinical benefits of early triptan therapy for migraine. Cephalalgia. 2004 24 (Suppl. 2 24 30. (Pubitemid 39626214)
15. Dowson AJ, Massiou H, Lainez JM, Cabarrocas X. Almotriptan improves response rates when treatment is within 1 hour of migraine onset. Headache. 2004 44 : 318 322. (Pubitemid 38541834)
16. Brandes J, Kudrow D, Cady R, Tiseo P, Sun W, Sikes C. Eletriptan in the early treatment of acute migraine: Influence of pain intensity and time of dosing. Cephalalgia. 2005 25 : 735 742. (Pubitemid 41208315)
17. Dodick D, Silberstein S. Central sensitization theory of migraine: Clinical implications. Headache. 2006 46 (Suppl. 4 S182 S191. (Pubitemid 44656903)
18. Cady R, Martin V, Mauskop A, et al. Efficacy of rizatriptan 10 mg administered early in a migraine attack. Headache. 2006 46 : 914 924. (Pubitemid 43794743)
19. Dowson AJ, Mathew NT, Pascual J. Review of clinical trials using early acute intervention with oral triptans for migraine management. Int J Clin Pract. 2006 60 : 698 706. (Pubitemid 43811651)
20. Freitag FG, Finlayson G, Rapoport AM, et al. Effect of pain intensity and time to administration on responsiveness to almotriptan: Results from AXERT 12.5 mg Time Versus Intensity Migraine Study (AIMS). Headache. 2007 47 : 519 530. (Pubitemid 46625261)
21. Goadsby PJ, Vila C, on behalf Of The Asg. 'ACT when mild': Early vs. non-early almotriptan intervention in migraine. Cephalalgia. 2006 26 : 1393 1394.
22. Goadsby PJ, Zanchin G, Geraud G, et al. Early vs. non-early intervention in acute migraine-'Act when Mild (AwM)'. A double-blind, placebo-controlled trial of almotriptan. Cephalalgia. 2008 28 : 383 391. (Pubitemid 351341454)
23. Klapper J, Lucas C, Rosjo O, Charlesworth B. Benefits of treating highly disabled migraine patients with zolmitriptan while pain is mild. Cephalalgia. 2004 24 : 918 924. (Pubitemid 39471916)
24. Mathew NT, Kailasam J, Meadors L. Early treatment of migraine with rizatriptan: A placebo-controlled study. Headache. 2004 44 : 669 673. (Pubitemid 38931897)
25. Pascual J, Cabarrocas X. Within-patient early versus delayed treatment of migraine attacks with almotriptan: The sooner the better. Headache. 2002 42 : 28 31. (Pubitemid 34136608)
26. Scholpp J, Schellenberg R, Moeckesch B, Banik N. Early treatment of a migraine attack while pain is still mild increases the efficacy of sumatriptan. Cephalalgia. 2004 24 : 925 933. (Pubitemid 39471917)
27. Hershey AD, Winner P, Kabbouche MA, et al. Use of the ICHD-II criteria in the diagnosis of pediatric migraine. Headache. 2005 45 : 1288 1297. (Pubitemid 350004941)
28. Mathew NT. Efficacy and tolerability of almotriptan in controlled clinical trials. Eur Neurol. 2005 53 (Suppl. 1 29 33. (Pubitemid 40827683)
29. Mathew NT. Early intervention with almotriptan improves sustained pain-free response in acute migraine. Headache. 2003 43 : 1075 1079.
30. Mathew NT, Finlayson G, Smith TR, et al. Early intervention with almotriptan: Results of the AEGIS trial (AXERT Early Migraine Intervention Study). Headache. 2007 47 : 189 198. (Pubitemid 46246321)
31. Evers S, Rahmann A, Kraemer C, et al. Treatment of childhood migraine attacks with oral zolmitriptan and ibuprofen. Neurology. 2006 67 : 497 499. (Pubitemid 44214980)